Canada Pension Plan Investment Board’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-35,200
Closed -$427K – 1917
2025
Q4
$427K Buy
35,200
+33,200
+1,660% +$403K ﹤0.01% 1362
2025
Q3
$23.4K Buy
+2,000
New +$23.9K ﹤0.01% 1303
2025
Q2
– Sell
-81,800
Closed -$600K – 1427
2025
Q1
$600K Buy
81,800
+81,000
+10,125% +$623K ﹤0.01% 950
2024
Q4
$6.83K Buy
+800
New +$7.8K ﹤0.01% 1380

Other funds holding OCUL

Canada Pension Plan Investment Board's OCUL Position: Q1 2026 in Review

Canada Pension Plan Investment Board sold out of Ocular Therapeutix (OCUL) in Q1 2026, closing a stake of 35,200 shares — an estimated $427K sold.

Canada Pension Plan Investment Board first reported a position in OCUL in Q4 2024 and held it in 4 quarters. The position peaked at $600K in Q1 2025. 271 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • Canada Pension Plan Investment Board reported no remaining Ocular Therapeutix position as of Q1 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 35,200 Ocular Therapeutix shares in Q1 2026, an estimated $427K.
  • Canada Pension Plan Investment Board first reported a position in Ocular Therapeutix in Q4 2024 and held it in 4 quarters.
  • Canada Pension Plan Investment Board's Ocular Therapeutix position peaked at $600K in Q1 2025.
  • 271 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.